Company Filing History:
Years Active: 2004-2021
Title: Carsten Olbrich - Innovator in Pharmaceutical Science
Introduction
Carsten Olbrich is a distinguished inventor based in Berlin, Germany, renowned for his significant contributions to the field of pharmaceutical sciences. With a total of four patents to his name, he has demonstrated a commitment to advancing medical treatments and formulations.
Latest Patents
Olbrich's latest inventions include a formulation for bispecific T-cell engagers (BiTEs), which pertains to stable pharmaceutical compositions that comprise polypeptides with at least two antigen-binding domains, particularly suitable for subcutaneous administration. This innovation focuses on providing liquid compositions that minimize the formation of undesired polypeptide aggregates, thereby enhancing the effectiveness of treatments.
In addition, he has developed a method for the production of freeze-dried pellets comprising factor VIII. This method involves freezing droplets of a solution containing factor VIII to create pellets, followed by freeze-drying them in a rotating receptacle housed inside a vacuum chamber. Such advancements are crucial for improving the stability and availability of vital pharmaceutical products.
Career Highlights
Carsten Olbrich has had a notable career with key positions in esteemed companies such as Pharmasol GmbH and Amgen Inc. His involvement in these organizations showcases his pivotal role in the development of innovative pharmaceutical solutions and treatments.
Collaborations
Throughout his career, Olbrich has collaborated with talented professionals, including his coworkers Rainer Helmut Müller and Thomas Bunte. These partnerships reflect the collaborative spirit prevalent in the research community, contributing to the successful development and commercialization of groundbreaking medical technologies.
Conclusion
Carsten Olbrich’s innovative spirit and dedication to pharmaceutical research exemplify the qualities of a successful inventor. With his impressive patents and collaborative efforts, he continues to impact the medical field significantly, paving the way for novel treatments that enhance patient care and outcomes.